IRVINE, Calif., Oct. 27, 2005 (PRIMEZONE) -- "As the predicted boom in the biotech and pharmaceutical sectors edges ever closer, companies are finding inventive ways to increase their visibility and push for competitive advantages while expanding their revenue base," stated SmallCap Sentinel analyst D.R. Clark. "This trend is exemplified by the recent agreement between Biophan Technologies, Inc. (OTCBB:BIPH) and medical device manufacturer, Boston Scientific (NYSE:BSX), involving a licensing agreement for the use of certain Biophan technologies for MRI safety and image compatibility as well as a broad range of other product lines."
"Biophan and others are looking to leverage their core technologies and intellectual properties through such agreements. Getting the product to market in one form or another is critical," said Clark. "A recent Barron's report suggested that Boston Scientific would likely see its market-share bolstered as its growing product pipeline makes meaningful contributions to its profits in the next several years, a bullish comment that could probably be applied to a number of aggressive biotechnology companies scrambling for market dominance."
An informational report "The Silver Tsunami: Baby Boomers & Biotech Breakthroughs" has been made available free of charge via financial courier StockUpTicks.com at www.SmallCapSentinel.com
The report will detail various issues affecting the current market for biotechnology companies including those mentioned above as well as Merit Medical Systems Inc. (Nasdaq:MMSI) and FoxHollow Technologies, Inc. (Nasdaq:FOXH).
Biophan develops and markets cutting-edge technologies designed to make biomedical devices safe and compatible with the magnetic resonance imaging (MRI) environment. The company develops enabling technologies for implanted medical systems such as pacemakers and interventional surgical devices such as catheters, guidewires, stents, and other implants to allow them to be safely and effectively imaged under MRI. Additional information regarding Biophan is available at: http://trilogy-capital.com/biph_summary.aspx
Individuals may also register for future reports at: http://stockupticks.com/register.html
Statements made herein contain forward-looking statements and are subject to significant risks and uncertainties that affect results. SmallCap Sentinel and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect any proposed actions and cannot project capabilities, intent, resources, or experience.
All information contained herein is based upon sources believed to be reliable but no representation is made as to its accuracy or completeness. This report is neither a solicitation to buy, nor offer to sell securities but is rather a paid advertisement provided for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor and this report is not investment advice. MP has been paid $1,500 by Biophan for preparation and distribution of this report and other advertising services. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject companies.